Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-29
2000-11-07
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546157, 546158, A61K 314704, C07D215227
Patent
active
061437638
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
The invention relates to novel carbostyril derivatives being useful as medicines in the prophylaxis or treatment of various ischemic diseases.
BACKGROUND ART
Ischemic diseases such as thrombosis or arteriosclerosis may break out and become worse by a complicated interaction of three factors of the change in the components in the blood fluid, the abnormal blood flow and the disorder of the blood vessel wall. Although thrombosis is caused by various factors, it mainly breaks out by the disorder of the intima cells like in the case of atherosclerosis, subsequently the activation of platelets, and then by the adhesion and aggregation of platelets.
Arteriosclerosis breaks out and becomes worse by the growth of the blood vessel smooth muscle cells by the complicated interaction of the above mentioned three factors, and then by the thickening of the intima.
Thus, it is very important that a medicant being useful in the prophylaxis or treatment of ischemic diseases such as thrombosis or arteriosclerosis should essentially show both antithrombotic activity and intima thickening inhibitory activity.
There are known various carbostyril derivatives. For example, WO 93/04042 (=JP-A-5-194405) discloses carbostyril derivatives of the formula: ##STR2## wherein A is a lower alkylene; R is --NR.sup.1 R.sup.2, --SO.sub.2 NR.sup.3 R.sup.4, or --Y--NR.sup.5 R.sup.6 ; R.sup.1 is --(CO).sub.1 --B--(CO).sub.m --NR.sup.7 R.sup.8 or --SO.sub.2 --D--R.sup.9 ; R.sup.2 is H, a cycloalkyl, a substituted or unsubstituted phenyl, etc.; or R.sup.1 and R.sup.2 may combine with the adjacent nitrogen to form a substituted or unsubstituted pyrrolidinyl; R.sup.3 is H, lower alkyl, --E--(CO).sub.n --NR.sup.10 R.sup.11, etc.; R.sup.4 is H, a cycloalkyl, a substituted or unsubstituted phenyl, a heterocyclic group-substituted alkyl, etc.; Y is --NHCO--, --NHC(=S)--or --C(.dbd.S)--; R.sup.5 and R.sup.6 are each H, a lower alkyl, a cycloalkyl, a piperidinyl-alkyl, etc.; and W is O or S, which have a platelet aggregation inhibitory activity and a platelet adhesion inhibitory activity. Some compounds inclusive in the general formula of the present invention may fall within the scope of the general formula of this prior art, and those possibly overlapping compounds are excluded from the present invention by the proviso phrase.
U.S. Pat. Nos. 4,070,470, 4,216,220 and 4,313,947 disclose carbostyril derivatives of the formula: ##STR3## wherein R.sup.1 is H, lower alkyl, lower alkenyl or aralkyl, R.sup.4 is OH, alkoxy, substituted or unsubstituted amino, heterocyclic amino, etc., A is lower alkylene or vinylene, B is --CH.sub.2 --, --CH.sub.2 CH.sub.2 -- or --CH.dbd.CH--, and m and n are 0 or a positive integer with m+n being no more than 11, which have a platelet ag gregation inhibitory activity.
U.S. Pat. No. 4,298,739 discloses carbostyril derivatives of the formula: ##STR4## wherein R.sup.1 is H, lower alkyl, lower alkenyl or phenylalkyl, R.sup.2 is H, halogen, OH or phenylalkoxy, R.sup.3 is H, OH or lower alkyl, R.sup.4 is cycloalkyl, substituted or unsubstituted phenyl, cycloalkylalkyl, etc., R.sup.5 is H, alkyl, lower alkenyl, phenyl, cycloalkyl, etc., m is 1-3, and l and n are 0 or an integer of 1-7, which have a platelet aggregation inhibitory activity.
U.S. Pat. No. 4,435,404 discloses carbostyril derivatives of the formula: ##STR5## wherein R.sup.1 is H, R.sup.2 is H or lower alkyl, R.sup.3 is hydroxy-lower alkyl having 1 to 3 hydroxy groups, lower alkanoyloxy-lower alkyl, etc., R.sup.4 is cycloalkyl having 1 to 3 hydroxy groups, etc., or R.sup.3 and R.sup.4 form a group of the formula: ##STR6## (R.sup.3 is phenyl, etc.), A is lower alkylene, which have a platelet aggregation inhibitory activity.
EP-A-0450066 (published on Oct. 9, 1989) discloses carbostyril derivatives of the formula: ##STR7## wherein R.sup.1 is substituted or unsubstituted cycloalkyl-lower alkyl, cycloalkyl, substituted or unsubstituted phenyl, piperidinyl-lower alkyl, etc., R.sup.2 is substituted or unsubstituted heterocyclo-lower alkyl, pyridylthio-lower
REFERENCES:
patent: 5506239 (1996-04-01), Sato et al.
Koga et al., "2(1H)-Quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activites," Bioorganic & Medicinal Chem. Letters, vol. 8, No. 12, pp. 1471-1476, Jun. 16, 1998.
Fukuda Norio
Hidaka Hiroyoshi
Inoue Yoshihiro
Kihara Yoshito
Kimura Yukio
D. Western Therapeutics Institiute
Raymond Richard L.
LandOfFree
Carbostyril derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbostyril derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbostyril derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641454